COTARGETING THE LNCRNA-DEPENDENT AKT/PI3K AND YAP SIGNALING: A NOVEL PARADIGM FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

$717,371FY2019Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators